Submitted by Anonymous (not verified) on 17 September 2025 - 11:10
Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Date of authorisation: 17/07/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Date of authorisation: 17/07/2025, Status: Authorised